Ralington Pharma Llp - Company Profile

It is a pharma limited liability partnership based in Sanand, Gujarat, India, established in 2015.
2015 Sanand, Gujarat, India Active
Last Updated:
Access Report
About Ralington Pharma Llp

Ralington Pharma Llp, a active limited liability partnership, was established on 01 June 2015 in Sanand, Gujarat, India. Engaging in drug formulation & development within the pharma sector, it holds LLPIN: AAE-0673. Registered under ROC Roc Ahmedabad. It has total obligation of contribution of ₹50.00 K .

Its leadership includes Kartik Harshad Barot (Designated Partner), Dipesh Ramjibhai Gadhavi (Designated Partner), Smita Kartik Barot (Designated Partner). Past directors included Dipesh Ramjibhai Gadhavi. Its latest date of accounts and solvency statement 31 March 2025. It is based at Plot No 32 And 33, Sunshine Industrial Estate,, Navapura , Changodhar,, Sanand, Gujarat, 382213.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAE-0673

  • Incorporation Date

    01 June 2015

  • Total Obligation of Contribution

    ₹50.00 K

  • ROC Code

    Roc Ahmedabad

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 50.00 K
  • Company Age 10 Year, 8 Months
  • Last Filing with ROC 31 Mar 2025
Company report

Ralington Pharma Llp

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Ralington Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report Banner Element
Who are the key members and board of directors at Ralington Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Kartik Harshad Barot Designated Partner 01 Jun 2015 Current
Dipesh Ramjibhai Gadhavi Designated Partner 01 Jun 2015 Current
Smita Kartik Barot Designated Partner 02 Apr 2024 Current
Past Designated Partners
Name Designation Cessation Status
Pramod Abcsdd Designated Partner 02 Apr 2024 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Ralington Pharma Llp.

Ralington Pharma Llp, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.

Ralington Pharma Llp revenue growth over time
Ralington Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Ralington Pharma Llp?

Unlock access to Ralington Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Ralington Pharma Llp?

Unlock and access historical data on people associated with Ralington Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Ralington Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ralington Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Ralington Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    Ralington Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records. was recorded as a recent event.

  • Statement of Assets & Liabilities

    The activity Ralington Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.

  • Director Appointment

    Smita Kartik Barot was appointed as a Designated Partner was appointed as a Designated Partner on 02 Apr 2024 & has been associated with this company since 1 year 10 months . was recorded as a recent event.

  • Director Appointment

    Kartik Harshad Barot was appointed as a Designated Partner was appointed as a Designated Partner on 01 Jun 2015 & has been associated with this company since 10 years 8 months . was recorded as a recent event.

  • Director Appointment

    Progress on Dipesh Ramjibhai Gadhavi was appointed as a Designated Partner was appointed as a Designated Partner on 01 Jun 2015 & has been associated with this company since 10 years 8 months . was documented.

  • LLP Incorporation

    The activity Ralington Pharma Llp was registered on 01 Jun 2015 with Roc Ahmedabad & aged 10 years 8 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Ralington Pharma Llp?

The LLPIN of Ralington Pharma Llp is AAE-0673.

Where is Ralington Pharma Llp headquartered?

Ralington Pharma Llp is headquartered at Plot No 32 And 33, Sunshine Industrial Estate,, Navapura , Changodhar,, Sanand, Gujarat, 382213.

When was Ralington Pharma Llp incorporated?

Ralington Pharma Llp was incorporated on 01 June 2015.

Who are the current directors of Ralington Pharma Llp?

The current directors of Ralington Pharma Llp are

What is the primary industry of Ralington Pharma Llp?

The primary industry of Ralington Pharma Llp is Pharma.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available